Korean J Med.
2003 Nov;65(Suppl 3):S863-S866.
A case of eosinophilic pneumonia under chemotherapy with the combination of 5-fluorouracil and leucovorin for colon cancer
- Affiliations
-
- 1Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea. kimhj@mail.donga.ac.kr
Abstract
- The combination of 5-fluorouracil and leucovorin is the most commonly used chemotherapeutic agents in colon cancer. The most frequent adverse effects include mucositis, diarrhea and myelosuppression. But it has never been reported that eosinophilic pneumonia developed. A 50-year-old woman with a history of colon cancer was treated by chemotherapy with a combination of 5-fluorouracil and leucovorin. Progressive dyspnea and bilateral pulmonary interstitial infiltrates developed. Bronchoscopy with bronchoalveolar lavage confirmed pulmonary eosinophilia. Clinical and radiologic aspects of eosinophilic pneumonia cleared after discontinuation of chemotherapy. We report the first case of eosinophilic pneumonia induced by 5-fluorouacil and leucovorin administration in a patient with colon cancer.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- 5-fluorouracil and low dose leucovorin combination chemotherapy for metastatic or recurrent colorectal cancer
- A Case of Organizing Pneumonia Associated with FOLFIRI Chemotherapy
- Neutropenic Enterocolitis after Chemotherapy for Colon Cancer
- 5-Fluorouracil, Leucovorin ( FL ) Combination Chemotherapy in Advanced or Recurrent Colo - rectal Cancer
- Adjuvant Chemotherapy in Gastric Cancer
